Antecedent-consequent variable concept applied to N2OO2 administration in stage 1-analgesia. Part 2-the characteristic somatic responses.

Antecedent-consequent variable concept applied to N2OO2 administration in stage 1-analgesia. Part 2-the characteristic somatic responses. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Antecedent-consequent variable concept applied to N2OO2 administration in stage 1-analgesia. Part 2-the characteristic somatic responses. Abstract Text:

Antecedent-consequent variable concept applied to N2OO2 administration in stage 1-analgesia. Part 2-the characteristic somatic responses. Publishing Authors By Initials

For similar nervous system diseases: neurologic manifestations: pain research abstracts see: nervous system diseases: neurologic manifestations: pain research

PUBMED ID PMID:

MEDLINE DATE: 1973 Oct-Dec

Antecedent-consequent variable concept applied to N2OO2 administration in stage 1-analgesia. Part 2-the characteristic somatic responses. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Journal. National Analgesia Society

VOLUME: 2

Page Numbers: 101-13

Journal Abbreviation:

ISSN:

DAY: 3

MONTH: 03

YEAR: 2008

Antecedent-consequent variable concept applied to N2OO2 administration in stage 1-analgesia. Part 2-the characteristic somatic responses. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 330010

Antecedent-consequent variable concept applied to N2OO2 administration in stage 1-analgesia. Part 2-the characteristic somatic responses. Keywords Mesh Terms:

KEYWORDS: Pain

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Antecedent-consequent variable concept applied to N2OO2 administration in stage 1-analgesia. Part 2-the characteristic somatic responses. Information

Substance Name: Nitrous Oxide

Registry Number: 10024-97-2

Grant and Affiliation Information for Antecedent-consequent variable concept applied to N2OO2 administration in stage 1-analgesia. Part 2-the characteristic somatic responses.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Natl Analg Soc

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Antecedent-consequent variable concept applied to N2OO2 administration in stage 1-analgesia Part 2-the characteristic somatic responses Related Publications

• A comparison of cannulas number 1104 and number 66.
• Altered state of consciousness. IV. The relationship between N2-O2 experience and the hypnotic experience. Section C. A technic for using NZO-O2 and hypnosis together.
• Altered state of consciousness. IV. The relationship between the N20-02 experience and the hypnotic experience.
• Altered state of consciousness. IV. The relationship between the N2O-O2 experience and the hypnotic experience.
• Antecedent-consequent variable concept applied to N2OO2 administration in stage 1-analgesia. Part 2-the characteristic somatic responses.
• Antecedent-consequent variables of N2O-O2 administration in stage I analgesia.
• Antecedent-consequent variables of N2O-O2 administration in state 1 analgesia. V. The anxiety-relaxation profiles.
• Antecedent-consequent variables of N2O-O2 administration. I. Behavioral profile of the patient.
• Anxiety and relaxation tests for N2OO2 sedation.
• Hypnosis and N2O-O2 sedation.
• Hypnosis and N2O-O2 sedation. Part 4.
• Physical factors of N2O and O2. Part 3. Commercial production of O2 and N2O.
• Physical factors of N2O and O2. Part 4. Solubility.
• Physical factors of N2O and O2. Part V. Pharmacokinetics; relevant administrative pharmacological factors.
• Physical factors of N2O and O2. Part VI. Pharmacodynamics.
• Recent mortality decline in Illinois.
• The constant 02 flow method of administration of N20-02.
• The pharmacology of N20-02 sedation.
• The pre-excitement plateau in stage 1 N2O-O2 administration.
• The relaxation plateau in stage 1 N20-02 administration.